Stock listing
Celon Pharma Sa
Selected listing: CLN · GPW · PLN · PL
Celon Pharma Sa (GPW:CLN), Health Technology. Latest release Oct 8, 2025: FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial.
- Ticker
- GPW:CLN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GPW
- Currency
- PLN
About Celon Pharma Sa
Celon Pharma Sa is a public company listed on the Polish market under the ticker CLN. Celon Pharma focuses on the development and commercialization of innovative therapies in the pharmaceutical sector.
Latest news from Celon Pharma Sa
FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial
October 8, 2025
Celon Pharma S A : Doubled export sales, continuation of the strategy of investing in research and development
September 29, 2021
Celon Pharma S A : Announces Successful Completion of Phase 1A Trial of CPL’116, JAK-ROCK Inhibitor.
February 10, 2021
Research Celon Pharma Sa
Alternate listings
0RKX:LSE
GB · PLN
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.
A2DJW6:LSX
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.
8RP:GETTEX
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.
8RP:DUS
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.
8RP:FWB
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.
A2DJW6:LS
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.
8RP:MUN
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.
8RP:SWB
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is CLN:GPW.